|
Age, years
|
52.7 ± 11.1
|
57.1 ± 10.9
|
57.3 ± 11.0
|
0.912
|
|
Male, n (%)
|
106 (89.8)
|
102 (91.1)
|
82 (85.4)
|
0.401
|
|
Hypertension, n (%)
|
42 (35.6)
|
54 (48.2)*
|
57 (59.4)*
|
0.002
|
|
Hyperlipidemia, n (%)
|
54 (45.8)
|
59 (56.2)
|
52 (54.2)
|
0.334
|
|
Diabetes mellitus, n (%)
|
17 (14.4)
|
18 (16.1)
|
23 (24.0)
|
0.175
|
|
Smoking, n (%)
|
85 (72.0)
|
80 (71.4)
|
62 (64.6)
|
0.052
|
|
BMI, kg/m2
|
25.9 ± 3.2
|
25.4 ± 2.9
|
26.3 ± 3.0
|
0.106
|
|
Anterior infarction, n (%)
|
67 (56.8)
|
53 (47.3)
|
39 (40.6)
|
0.059
|
|
Killip Class I on admission, n (%)
|
116 (98.3)
|
110 (98.2)
|
91 (94.8)
|
0.219
|
|
Maximum value of CK, IU/L
|
1421 ± 801
|
1370 ± 770
|
1460 ± 879
|
0.730
|
|
LVEDD, mm
|
49.6 ± 4.5
|
49.3 ± 6.8
|
50.3 ± 5.7
|
0.401
|
|
LVEF,%
|
57.1 ± 8.9
|
57.3 ± 10.1
|
55.9 ± 9.0
|
0.592
|
|
Gensini’s score
|
---
|
63.2 ± 37.0
|
65.2 ± 36.5
|
0.814
|
|
IRA
| | | |
0.080
|
|
LM, n (%)
|
0 (0)
|
0 (0)
|
0 (0)
| |
|
LAD, n (%)
|
70 (59.3)
|
57 (50.9)
|
38 (39.6)
| |
|
LCX, n (%)
|
16 (13.6)
|
18 (16.1)
|
18 (18.6)
| |
|
RCA, n (%)
|
32 (27.1)
|
37 (33.0)
|
40 (41.7)
| |
|
Medication usage at the time of CPET, n (%)
| | | | |
|
RAAS blockers
|
102 (86.4)
|
98 (87.5)
|
88 (91.7)
|
0.467
|
|
ß-blockers
|
95 (80.5)
|
80 (71.4)
|
69 (71.9)
|
0.207
|
|
Statins
|
101 (85.6)
|
95 (84.8)
|
80 (83.3)
|
0.900
|
